XML 50 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Detail of Certain Accounts (Tables)
 3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cash and Cash Equivalents Amounts related to cash and cash equivalents held by consolidated or proportionately consolidated joint ventures and the captive insurance company, which are included in Quanta’s total cash and cash equivalents balances, were as follows (in thousands):
 March 31, 2024December 31, 2023
Cash and cash equivalents held by domestic joint ventures$88,264 $41,427 
Cash and cash equivalents held by foreign joint ventures10,192 10,968 
Total cash and cash equivalents held by joint ventures98,456 52,395 
Cash and cash equivalents held by captive insurance company18,766 19,088 
Cash and cash equivalents not held by joint ventures or captive insurance company413,834 1,218,765 
Total cash and cash equivalents$531,056 $1,290,248 
Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses consisted of the following (in thousands):
 March 31, 2024December 31, 2023
Accounts payable, trade$1,848,562 $2,027,588 
Accrued compensation and related expenses393,990 526,221 
Other accrued expenses514,994 507,433 
Accounts payable and accrued expenses$2,757,546 $3,061,242